ABOS 8-K 2026-09-16

Acumen Pharmaceuticals, Inc. (ABOS) 8-K dated 2026-09-16 — accession 0001628280-26-062137. This URL is the filing, not the ABOS hub.

Acumen Pharmaceuticals, Inc. (ABOS) is a biotechnology company listed on US.

Acumen Pharmaceuticals, Inc. filed a 8-K on 2026-09-16. Accession 0001628280-26-062137.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ABOS revenue for 2023-12-31 was $10.8M. Net income was -$52.4M. ABOS currently screens at market cap $73.3M.

Not investment advice. The ABOS SEC hub lists recent forms. The stock page is the research view.